Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma

Pathology and Oncology Research

Volumn 5, Issue 3, 1999, Pages 214-217

  Du, Bo ^a   Wang, Ping ^a   Guo, Xiaofeng ^a   Du, Baodong ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Invasion; Laryngeal carcinoma; Metastasis; MT1 MMP

Indexed keywords

COLLAGENASE; GELATINASE A; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY;

EID: 0032710724     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1053/paor.1999.0217     Document Type: Article

References (14)

1. Matrisian L M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121-125.
2. Woessner J FJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:1991;2145-2154.
3. Cao J, Sato H, Takino T. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required of pro-gelatinase A activation. J Biol Chem. 270:1995;801-805.
4. Emonard H P, Remacle A G, Noel A C. Tumor cell surface-associated binding site for the Mr 72.000 type IV collagenase. Cancer Res. 52:1992;5845-5848.
5. Pei D, Weiss S. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process proglatianse A and express intrinsic matrix-degrading activity. J Biol Chem. 271:1996;9135-9140.
6. Kinoshita T, Sato H, Takino T. Processing of a precursor of 72kDa type IV collagenase/gelatinase A by a recombinant membrane type 1 matrix metalloproteinase. Cancer Res. 56:1996;2535-2538.
7. Sato H, Takino T, Okada Y. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature. 370:1994;61-65.
8. Bando E, Yonemura Y, Endou Y. Immunohistochemical study of MT-MMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol Rep. 5:1998;1483-1488.
9. Mori M, Mimori K, Shiraishi T. Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer. 74:1997;316-321.
10. Yamamoto M, Mahanam S, Sawaya R. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res. 56:1996;384-392.
11. Gilles C, Polette M, Piette J. High level of MT1-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer. 65:1996;209-213.
12. Tokuraku M, Sato H, Shinagawa A. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinoma correlation with the expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) and with lymph node metastasis. Int J Cancer. 64:1995;355-359.
13. Yoshizaki T, Sato H, Maruyama Y. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer. 79:1977;139-144.
14. Répássy G, Forster-Horváth Cs, Juhász A. Expression of invasion markers CD44v6/v3, nm23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res. 4:1998;14-22.